Ece Kadioglu
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Phagocytosis and Immune Regulation
Papers in
-
- Cancer, Hypoxia, and Metabolism 2
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 2
- HER2/EGFR in Cancer Research 1
- Co-authors
- Michele De Palma (6 shared papers)Nicolò Rigamonti (2 shared papers)Martina Schmittnaegel (2 shared papers)Anna Kiialainen (1 shared paper)Ioanna Keklikoglou (3 shared papers)Yvonne Kienast (1 shared paper)Chia-Huey Ooi (1 shared paper)Damya Laoui (1 shared paper)
- Journals
- Cell Reports (2 papers)Science Translational Medicine (2 papers)The Journal of Pathology (1 paper)Cancer Discovery (1 paper)npj Digital Medicine (1 paper)
- Partner nations
- SwitzerlandGermanySpain
In The Last Decade
Ece Kadioglu
9 papers receiving 1.0k citations
Ece Kadioglu's Hit Papers
Peers
Comparison fields: 5 of 62
- Cancer Research 251
- Immunology 370
- Oncology 449
- Molecular Biology 450
- Hepatology 44
Countries citing papers authored by Ece Kadioglu
This map shows the geographic impact of Ece Kadioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ece Kadioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ece Kadioglu more than expected).
Fields of papers citing papers by Ece Kadioglu
This network shows the impact of papers produced by Ece Kadioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ece Kadioglu. The network helps show where Ece Kadioglu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ece Kadioglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade Hit paper breakdown → | 2017 | 495 |
| 2 | 2014 | 212 | |
| 3 | 2017 | 125 | |
| 4 | 2021 | 73 | |
| 5 | 2021 | 38 | |
| 6 | 2018 | 34 | |
| 7 | 2022 | 23 | |
| 8 | 2015 | 18 | |
| 9 | 2023 | 10 |
About Ece Kadioglu
Ece Kadioglu is a scholar working on Cancer Research, Oncology, Obstetrics and Gynecology, Immunology and Cardiology and Cardiovascular Medicine, having authored 9 papers that have together received 1.0k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Endometrial and Cervical Cancer Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Immune cells in cancer (2 papers), Peptidase Inhibition and Analysis (2 papers), HER2/EGFR in Cancer Research (1 paper) and Ovarian cancer diagnosis and treatment (1 paper). The work is most often cited by research in Cancer Research (251 citations), Immunology (370 citations), Oncology (449 citations), Molecular Biology (450 citations) and Hepatology (44 citations). Ece Kadioglu has collaborated with scholars based in Switzerland, Germany and Spain. Frequent co-authors include Michele De Palma, Nicolò Rigamonti, Martina Schmittnaegel, Anna Kiialainen, Ioanna Keklikoglou, Yvonne Kienast, Chia-Huey Ooi, Damya Laoui, Ching Ching Leow and Carola Hermine Ries. Their work appears in journals such as Cell Reports, Science Translational Medicine, The Journal of Pathology, Cancer Discovery and npj Digital Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.